Casdin Private Growth Equity Fund, L.P.

CIK 1823061 · last filed 2025-08-15

Casdin Private Growth Equity Fund, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $3.5M of LAB on Aug 15, 2025. Across all open-market trades the lifetime net is +$8.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.01M

Companies

2

Total Filings

3

Lifetime Open-Market Net

$8.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LAB Director 5,645,281 $0.89 $5.01M $8.47M 2 2025-08-15
Verve Therapeutics, Inc. (VERV) Delisted 10%+ Owner 620,571 $11.13 $6.91M $0 1 2021-06-22

Recent Filings

3 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-08-15 LAB Buy (P) +2,865,760 $3.54M EDGAR
2024-08-29 LAB Buy (P) +2,250,000 $4.92M EDGAR
2021-06-22 Verve Therapeutics, Inc. (VERV) Delisted Conv (C) +620,571 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.